Cell-specific conditional deletion of interleukin-1 (IL-1) ligands and its receptors: a new toolbox to study the role of IL-1 in health and disease
暂无分享,去创建一个
A. Waisman | Werner Müller | N. Humphreys | S. Francis | E. Pinteaux | W. Abdulaal | I. Mufazalov | Maj Simonsen-Jackson
[1] A. Maqbool,et al. Fibroblast-specific deletion of IL-1 receptor-1 reduces adverse cardiac remodeling following myocardial infarction , 2019, JCI insight.
[2] R. Germain,et al. Host conditioning with IL-1β improves the antitumor function of adoptively transferred T cells , 2019, The Journal of experimental medicine.
[3] Ling Zhu,et al. Interleukin-1 causes CNS inflammatory cytokine expression via endothelia-microglia bi-cellular signaling , 2019, Brain, Behavior, and Immunity.
[4] T. Kiss,et al. Transfer of complex regional pain syndrome to mice via human autoantibodies is mediated by interleukin-1–induced mechanisms , 2019, Proceedings of the National Academy of Sciences.
[5] B. Becher,et al. Fate-Mapping of GM-CSF Expression Identifies a Discrete Subset of Inflammation-Driving T Helper Cells Regulated by Cytokines IL-23 and IL-1β. , 2019, Immunity.
[6] C. Garlanda,et al. Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity. , 2019, Immunity.
[7] R. Blakely,et al. Cell‐Type‐Specific Interleukin 1 Receptor 1 Signaling in the Brain Regulates Distinct Neuroimmune Activities , 2019, Immunity.
[8] N. Rothwell,et al. Interleukin-1 mediates ischaemic brain injury via distinct actions on endothelial cells and cholinergic neurons , 2019, Brain, Behavior, and Immunity.
[9] I. Holen,et al. Endogenous Production of IL1B by Breast Cancer Cells Drives Metastasis and Colonization of the Bone Microenvironment , 2019, Clinical Cancer Research.
[10] A. Dzutsev,et al. Cell‐Type‐Specific Responses to Interleukin‐1 Control Microbial Invasion and Tumor‐Elicited Inflammation in Colorectal Cancer , 2019, Immunity.
[11] G. Kollias,et al. Innate Sensing through Mesenchymal TLR4/MyD88 Signals Promotes Spontaneous Intestinal Tumorigenesis , 2019, Cell reports.
[12] J. Wynn,et al. Cutting Edge: IL-1α and Not IL-1β Drives IL-1R1–Dependent Neonatal Murine Sepsis Lethality , 2018, The Journal of Immunology.
[13] T. Schlüter,et al. Regulation of IL-1 signaling by the decoy receptor IL-1R2 , 2018, Journal of Molecular Medicine.
[14] V. V. Ganusov,et al. Cutting Edge: IL-1R1 Mediates Host Resistance to Mycobacterium tuberculosis by Trans-Protection of Infected Cells , 2018, The Journal of Immunology.
[15] R. Blakely,et al. Pancreatic deletion of the interleukin-1 receptor disrupts whole body glucose homeostasis and promotes islet β-cell de-differentiation , 2018, Molecular metabolism.
[16] A. Waisman,et al. Interleukin-1β promotes atheroprotective changes of advanced atherosclerotic lesions in mice , 2018, Nature Medicine.
[17] P. Galle,et al. Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation. , 2018, Journal of hepatology.
[18] C. Dinarello. Introduction to the interleukin‐1 family of cytokines and receptors: Drivers of innate inflammation and acquired immunity , 2018, Immunological reviews.
[19] D. Marks,et al. Interleukin-1β signaling in fenestrated capillaries is sufficient to trigger sickness responses in mice , 2017, Journal of Neuroinflammation.
[20] A. Blomqvist,et al. Involvement of interleukin-1 type 1 receptors in lipopolysaccharide-induced sickness responses , 2017, Brain, Behavior, and Immunity.
[21] J. Martínez-Quiroz,et al. Interleukin-1β increases neuronal death in the hippocampal dentate gyrus associated with status epilepticus in the developing rat. , 2017 .
[22] J. Martínez-Quiroz,et al. Interleukin-1β increases neuronal death in the hippocampal dentate gyrus associated with status epilepticus in the developing rat. , 2017, Neurologia.
[23] K. Flaherty,et al. An adaptive signaling network in melanoma inflammatory niches confers tolerance to MAPK signaling inhibition , 2017, The Journal of experimental medicine.
[24] C. Gabay,et al. Deficiency in IL-1 Receptor Type 2 Aggravates K/BxN Serum Transfer-Induced Arthritis in Mice but Has No Impact on Systemic Inflammatory Responses , 2017, The Journal of Immunology.
[25] A. Waisman,et al. IL‐1 signaling is critical for expansion but not generation of autoreactive GM‐CSF+ Th17 cells , 2017, The EMBO journal.
[26] A. Waisman,et al. Generation of a Novel T Cell Specific Interleukin-1 Receptor Type 1 Conditional Knock Out Mouse Reveals Intrinsic Defects in Survival, Expansion and Cytokine Production of CD4 T Cells , 2016, PloS one.
[27] R. Blakely,et al. Generation and Characterization of Mice Expressing a Conditional Allele of the Interleukin-1 Receptor Type 1 , 2016, PloS one.
[28] N. Rothwell,et al. Characterization of a conditional interleukin‐1 receptor 1 mouse mutant using the Cre/LoxP system , 2016, European journal of immunology.
[29] Frauke Zipp,et al. Genetic Cell Ablation Reveals Clusters of Local Self-Renewing Microglia in the Mammalian Central Nervous System. , 2015, Immunity.
[30] Y. Iwakura,et al. IL-1 receptor antagonist-deficient mice develop autoimmune arthritis due to intrinsic activation of IL-17-producing CCR2+Vγ6+γδ T cells , 2015, Nature Communications.
[31] D. Brough,et al. Interleukin‐1α and brain inflammation , 2015, IUBMB life.
[32] Y. Iwakura,et al. IL-1 Receptor Type 2 Suppresses Collagen-Induced Arthritis by Inhibiting IL-1 Signal on Macrophages , 2015, The Journal of Immunology.
[33] J. Sheridan,et al. Interleukin 1 Type 1 Receptor Restore: A Genetic Mouse Model for Studying Interleukin 1 Receptor-Mediated Effects in Specific Cell Types , 2015, The Journal of Neuroscience.
[34] J. Bugajski,et al. Cytokines, prostaglandins and nitric oxide in the regulation of stress-response systems , 2013, Pharmacological reports : PR.
[35] R. Shahar,et al. IL-1RI participates in normal growth plate development and bone modeling. , 2013, American journal of physiology. Endocrinology and metabolism.
[36] C. Dinarello,et al. Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice , 2013, Gut.
[37] J. Qian,et al. Interleukin-1R3 mediates interleukin-1–induced potassium current increase through fast activation of Akt kinase , 2012, Proceedings of the National Academy of Sciences.
[38] E. Pinteaux,et al. Oxygen–glucose deprivation and interleukin‐1α trigger the release of perlecan LG3 by cells of neurovascular unit , 2011, Journal of neurochemistry.
[39] Y. Iwakura,et al. IL-1 plays an important role in the bone metabolism under physiological conditions. , 2010, International immunology.
[40] R. Grencis,et al. IL‐1‐dependent, IL‐1R1‐independent resistance to gastrointestinal nematodes , 2009, European journal of immunology.
[41] N. Rothwell,et al. Differential effects of interleukin-1 alpha and beta on interleukin-6 and chemokine synthesis in neurones , 2008, Molecular and Cellular Neuroscience.
[42] C. Viebahn,et al. Focus on Mammalian Embryogenomics Blastocyst elongation, trophoblastic differentiation, and embryonic pattern formation , 2008 .
[43] David Evans,et al. Interleukin-1beta and signaling of interleukin-1 in vascular wall and circulating cells modulates the extent of neointima formation in mice. , 2006, The American journal of pathology.
[44] N. Rothwell,et al. Neuroprotective actions of endogenous interleukin‐1 receptor antagonist (IL‐1ra) are mediated by glia , 2006, Glia.
[45] N. Rothwell,et al. Gene regulation by IL‐1β independent of IL‐1R1 in the mouse brain , 2006, Glia.
[46] J. Dayer,et al. Decreased fat mass in interleukin-1 receptor antagonist-deficient mice: impact on adipogenesis, food intake, and energy expenditure. , 2005, Diabetes.
[47] N. Gérard,et al. In vivo effect of interleukin-1beta and interleukin-1RA on oocyte cytoplasmic maturation, ovulation, and early embryonic development in the mare , 2005, Reproductive biology and endocrinology : RB&E.
[48] F. Ohsuzu,et al. Lack of Interleukin-1 Receptor Antagonist Modulates Plaque Composition in Apolipoprotein E–Deficient Mice , 2004, Arteriosclerosis, thrombosis, and vascular biology.
[49] YoichiroIwakura,et al. Lack of Interleukin-1 Receptor Antagonist Modulates Plaque Composition in Apolipoprotein E–Deficient Mice , 2004 .
[50] Werner Müller,et al. Keratin 14 Cre transgenic mice authenticate keratin 14 as an oocyte‐expressed protein , 2004, Genesis.
[51] M. Little,et al. Psoriasis-like cutaneous inflammation in mice lacking interleukin-1 receptor antagonist. , 2004, The Journal of investigative dermatology.
[52] A. Martoriati,et al. The interleukin-1 system and female reproduction. , 2004, The Journal of endocrinology.
[53] J. Um,et al. Association of interleukin-1 alpha gene polymorphism with cerebral infarction. , 2003, Brain research. Molecular brain research.
[54] J. Um,et al. Interleukin-1 gene cluster polymorphisms in cerebral infarction. , 2003, Cytokine.
[55] N. Rothwell,et al. The expanding interleukin-1 family and its receptors , 2003, Molecular Neurobiology.
[56] M. Bähr,et al. Interleukin-1β protects neurons via the interleukin-1 (IL-1) receptor-mediated Akt pathway and by IL-1 receptor-independent decrease of transmembrane currents in vivo , 2003, Molecular and Cellular Neuroscience.
[57] N. Rothwell,et al. Interleukin-1 Influences Ischemic Brain Damage in the Mouse Independently of the Interleukin-1 Type I Receptor , 2002, The Journal of Neuroscience.
[58] S. Nakae,et al. IL-1α, but not IL-1β, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity , 2001 .
[59] P. Neveu,et al. Interleukin 1 receptor accessory protein (IL-1RAcP) is necessary for centrally mediated neuroendocrine and immune responses to IL-1β , 2000, Journal of Neuroimmunology.
[60] R. Dantzer,et al. Biological activity and brain actions of recombinant rat interleukin-1alpha and interleukin-1beta. , 1998, European cytokine network.
[61] K. McIntyre,et al. IL-1 receptor accessory protein is an essential component of the IL-1 receptor. , 1998, Journal of immunology.
[62] T. Bártfai,et al. Interleukin-1-mediated febrile responses in mice and interleukin-1 beta activation of NFkappaB in mouse primary astrocytes, involves the interleukin-1 receptor accessory protein. , 1998, European cytokine network.
[63] Masatoshi Suzuki,et al. Production of Mice Deficient in Genes for Interleukin (IL)-1α, IL-1β, IL-1α/β, and IL-1 Receptor Antagonist Shows that IL-1β Is Crucial in Turpentine-induced Fever Development and Glucocorticoid Secretion , 1998, The Journal of experimental medicine.
[64] P. Morrissey,et al. Phenotypic and functional characterization of mice that lack the type I receptor for IL-1. , 1997, Journal of immunology.
[65] K. Huebner,et al. A novel IL‐1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types. , 1991, The EMBO journal.
[66] Jan Born,et al. Brain-immune interactions in sleep. , 2002, International review of neurobiology.
[67] S. Nakae,et al. IL-1 alpha, but not IL-1 beta, is required for contact-allergen-specific T cell activation during the sensitization phase in contact hypersensitivity. , 2001, International immunology.